Perfil de la empresa · Healthcare

Solventum Corp.

SOLV · EE. UU.
Bolsa
EE. UU.
País / Región
USA
Fecha de salida a bolsa
26 de marzo de 2024
Empleados
20.584
Precio actual
$75.43
En vivo · 18 de junio de 2026
Compra razonable
≤ $65
Entrada con margen de seguridad
Puntuación de crecimiento Baillie
39/100
Floja
Valor intrínseco · Rango en tres niveles Precio actual $75.43 En vivo · Dentro del rango de valor intrínseco razonable

Rango de valoración compuesto · conservador $50–$65 / razonable $70–$90 / optimista $105–$135. A $75.43, Dentro del rango de valor intrínseco razonable.

Al publicar $74.95 (30 de mayo de 2026)

Aún no hay análisis sobre este valor en tu idioma.

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Capitalización13,32 mil MUS$
Ingresos (TTM)8262 MUS$
EBITDA1124 MUS$
Margen neto17,33 %
ROE34,79 %
PER (TTM)9,41
PER previsto11,74
PEG1,22
BPA8,17 US$
Rango de 52 semanas62,38 US$ – 88,20 US$
Precio objetivo de analistas82,15 US$
Recomendación de analistas3.3 / 5

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.